Fertility drugs and the risk of breast and gynecologic cancers

Seminars in Reproductive Medicine

Volumn 30, Issue 2, 2012, Pages 131-145

  Brinton, Louise A ^a   Sahasrabuddhe, Vikrant V ^a   Scoccia, Bert ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

cancer; infertility; ovulation inducing drugs; risk

Indexed keywords

CLOMIFENE; FERTILITY PROMOTING AGENT;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; DRUG EFFECT; DRUG MONITORING; ENDOMETRIUM CANCER; FEMALE; FERTILIZATION IN VITRO; GYNECOLOGIC CANCER; HORMONE RESPONSE; HUMAN; OVARY CANCER; UTERUS CANCER;

ADENOMATOUS POLYPS; ADOLESCENT; ADULT; BREAST NEOPLASMS; FEMALE; FERTILITY AGENTS; GENITAL NEOPLASMS, FEMALE; HUMANS; INFERTILITY, FEMALE; OVARIAN NEOPLASMS; OVULATION INDUCTION; RISK; YOUNG ADULT;

EID: 84860266365     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0032-1307421     Document Type: Article

References (105)

1. Cetin I, Cozzi V, Antonazzo P. Infertility as a cancer risk factora review. Placenta: 2008; 29 Suppl B 169 177
2. Wysowski DK. Use of fertility drugs in the United States, 1973 through 1991. Fertil Steril: 1993; 60 6 1096 1098 (Pubitemid 23359502)
3. Stephen EH, Chandra A. Updated projections of infertility in the United States: 1995-2025. Fertil Steril: 1998; 70 1 30 34 (Pubitemid 28294617)
4. Fathalla MF. Incessant ovulationa factor in ovarian neoplasia? Lancet: 1971; 2 7716 163
5. Henderson BE, Ross RK, Judd HL, Krailo MD, Pike MC. Do regular ovulatory cycles increase breast cancer risk? Cancer: 1985; 56 5 1206 1208 (Pubitemid 15003511)
6. Sovino H, Sir-Petermann T, Devoto L. Clomiphene citrate and ovulation induction. Reprod Biomed Online: 2002; 4 3 303 310
7. de Boer EJ, den Tonkelaar I, Burger CW, van Leeuwen FE.; OMEGA Project Group. Validity of self-reported causes of subfertility. Am J Epidemiol: 2005; 161 10 978 986 (Pubitemid 40656421)
8. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol: 1983; 61 4 403 407 (Pubitemid 13158697)
9. Dahlgren E, Friberg LG, Johansson S., et al. Endometrial carcinoma; ovarian dysfunctiona risk factor in young women. Eur J Obstet Gynecol Reprod Biol: 1991; 41 2 143 150
10. Escobedo LG, Lee NC, Peterson HB, Wingo PA. Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol: 1991; 77 1 124 128
11. Modan B, Ron E, Lerner-Geva L., et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol: 1998; 147 11 1038 1042
12. Baron JA, Weiderpass E, Newcomb PA., et al. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control: 2001; 12 10 875 880 (Pubitemid 34048867)
13. Cowan LD, Gordis L, Tonascia JA, Jones GS. Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol: 1981; 114 2 209 217 (Pubitemid 11051954)
14. Dor J, Lerner-Geva L, Rabinovici J., et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril: 2002; 77 2 324 327 (Pubitemid 34083556)
15. Moseson M, Koenig KL, Shore RE, Pasternack BS. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol: 1993; 22 6 1000 1009 (Pubitemid 24025676)
16. Potashnik G, Lerner-Geva L, Genkin L, Chetrit A, Lunenfeld E, Porath A. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril: 1999; 71 5 853 859 (Pubitemid 29206910)
17. Ron E, Lunenfeld B, Menczer J., et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol: 1987; 125 5 780 790 (Pubitemid 17066477)
18. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet: 1999; 354 9190 1586 1590 (Pubitemid 29515949)
19. Borgfeldt C, Andolf E. Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand: 2004; 83 4 395 400 (Pubitemid 38406822)
20. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol: 1997; 176 3 572 579 (Pubitemid 27147164)
21. Brinton LA, Lamb EJ, Moghissi KS., et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril: 2004; 82 2 405 414 (Pubitemid 39092042)
22. Duczman l, Ballweg ML. Endometriosis and Cancer: What Is the Connection? Endometriosis Association Newsletter: 1999
23. Ness RB, Cramer DW, Goodman MT., et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol: 2002; 155 3 217 224 (Pubitemid 34117299)
24. Risch HA, Howe GR. Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev: 1995; 4 5 447 451
25. Shu XO, Brinton LA, Gao YT, Yuan JM. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res: 1989; 49 13 3670 3674 (Pubitemid 19178194)
26. Whittemore AS, Harris R, Itnyre J.; Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol: 1992; 136 10 1184 1203 (Pubitemid 23026890)
27. Burkman RT, Tang MT, Malone KE., et al. Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril: 2003; 79 4 844 851 (Pubitemid 36385001)
28. Brinton LA, Lamb EJ, Moghissi KS., et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol: 2004; 103 6 1194 1203 (Pubitemid 40458949)
29. Klip H, Burger C, van Leeuwen F. The Omega Project Group. Risk of Hormone-Related Cancers after Ovarian Stimulation for In-Vitro Fertilisation in a Cohort of 25,152 Women. Enschede, the Netherlands PrintPartners Ipskamp BV: 2002
30. Lerner-Geva L, Keinan-Boker L, Blumstein T., et al. Infertility, ovulation induction treatments and the incidence of breast cancera historical prospective cohort of Israeli women. Breast Cancer Res Treat: 2006; 100 2 201 212 (Pubitemid 44631922)
31. Jensen A, Sharif H, Svare EI, Frederiksen K, Kjaer SK. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study. Cancer Epidemiol Biomarkers Prev: 2007; 16 7 1400 1407 (Pubitemid 47076870)
32. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med: 1994; 331 12 771 776 (Pubitemid 24284766)
33. Rossing MA, Daling JR. Complexity of surveillance for cancer risk associated with in-vitro fertilisation. Lancet: 1999; 354 9190 1573 1574 (Pubitemid 29515943)
34. Balasch J, Pahisa J, Mrquez M., et al. Metastatic ovarian strumosis in an in-vitro fertilization patient. Hum Reprod: 1993; 8 12 2075 2077
35. Dietl J. Ovulation and ovarian cancer. Lancet: 1991; 338 8764 445
36. Fuller PN. Malignant melanoma of the ovary and exposure to clomiphene citrate: a case report and review of the literature. Am J Obstet Gynecol: 1999; 180 6 Pt 1 1499 1503 (Pubitemid 29293278)
37. Goldberg GL, Runowicz CD. Ovarian carcinoma of low malignant potential, infertility, and induction of ovulationis there a link? Am J Obstet Gynecol: 1992; 166 3 853 854
38. Hull ME, Kriner M, Schneider E, Maiman M. Ovarian cancer after successful ovulation induction: a case report. J Reprod Med: 1996; 41 1 52 54 (Pubitemid 26037955)
39. Lopes P, Mensier A. Ovarian cancer and assisted reproductive technology. Eur J Obstet Gynecol Reprod Biol: 1993; 51 3 171 173 (Pubitemid 24013705)
40. Nijman HW, Burger CW, Baak JP, Schats R, Vermorken JB, Kenemans P. Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases. Eur J Cancer: 1992; 28A 12 1971 1973
41. Unkila-Kallio L, Leminen A, Tiitnen A, Lehtovirta P, Wahlström T, Ylikorkala O. Malignant tumors of the ovary or the breast in association with infertility: a report of thirteen cases. Acta Obstet Gynecol Scand: 1997; 76 2 177 181 (Pubitemid 27084724)
42. Willemsen W, Kruitwagen R, Bastiaans B, Hanselaar T, Rolland R. Ovarian stimulation and granulosa-cell tumour. Lancet: 1993; 341 8851 986 988 (Pubitemid 23109168)
43. Whittemore AS, Harris R, Itnyre J.; Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Am J Epidemiol: 1992; 136 10 1212 1220 (Pubitemid 23026892)
44. Caro JJ, Johannes CB, Hartz SC, Marrs R, Miettinen OS. Re: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white womeno" Am J Epidemiol: 1993; 137 8 928 929 (Pubitemid 23149671)
45. Cohen J, Forman R, Harlap S., et al. IFFS expert group report on the Whittemore study related to the risk of ovarian cancer associated with the use of infertility agents. Hum Reprod: 1993; 8 7 996 999 (Pubitemid 23204678)
46. Del Priore G, Robischon K, Phipps WR. Risk of ovarian cancer after treatment for infertility. N Engl J Med: 1995; 332 19 1300; author reply 1302
47. Shapiro S. Risk of ovarian cancer after treatment for infertility. N Engl J Med: 1995; 332 1301
48. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet: 1995; 346 8981 995 1000
49. Calderon-Margalit R, Friedlander Y, Yanetz R., et al. Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol: 2009; 169 3 365 375
50. Lerner-Geva L, Geva E, Lessing JB, Chetrit A, Modan B, Amit A. The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer: 2003; 13 1 23 27 (Pubitemid 36292720)
51. Croughan-Minihane M, Camarano L, Feigenbaum S., et al. The risk of ovarian cancer associated with infertility and infertility treatments. Fertil Steril: 2001; 76 S68
52. dos Santos Silva S, Wark PA, McCormack VA., et al. Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer: 2009; 100 11 1824 1831
53. Doyle P, Maconochie N, Beral V, Swerdlow AJ, Tan SL. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod: 2002; 17 8 2209 2213
54. Jensen A, Sharif H, Frederiksen K, Kjaer SK. Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study. BMJ: 2009; 338 b249
55. Källn B, Finnström O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Malignancies among women who gave birth after in vitro fertilization. Hum Reprod: 2011; 26 1 253 258
56. Sanner K, Conner P, Bergfeldt K., et al. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertil Steril: 2009; 91 4 1152 1158
57. Orgas CC, Sanner K, Hall P., et al. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study. Am J Obstet Gynecol: 2009; 200 1 72 77, e1-e7
58. Franceschi S, La Vecchia C, Negri E., et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod: 1994; 9 9 1673 1675 (Pubitemid 24291081)
59. Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril: 1997; 67 6 1005 1012 (Pubitemid 27241890)
60. Parazzini F, Negri E, La Vecchia C, Moroni S, Franceschi S, Crosignani PG. Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum Reprod: 1997; 12 10 2159 2161 (Pubitemid 27494022)
61. Parazzini F, Pelucchi C, Negri E., et al. Use of fertility drugs and risk of ovarian cancer. Hum Reprod: 2001; 16 7 1372 1375 (Pubitemid 32640310)
62. Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs. Am J Epidemiol: 2004; 160 11 1070 1078 (Pubitemid 39557459)
63. Kotsopoulos J, Librach CL, Lubinski J., et al; Hereditary Breast Cancer Clinical Study Group. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study. Cancer Causes Control: 2008; 19 10 1111 1119
64. Makrydimas G, Sotiriadis A, Paraskevaidis E, Pavlidis N, Agnantis N, Lolis D. Clear cell ovarian carcinoma in a pregnant woman with a history of infertility, endometriosis and unsuccessful IVF treatment. Eur J Gynaecol Oncol: 2003; 24 5 438 441 (Pubitemid 37236575)
65. Saylam K, Devreker F, Simon P, Fayt I, Nol JC. Ovarian clear cell carcinoma occurring in a young patient with endometriosis and long-term ovulation stimulations. Acta Obstet Gynecol Scand: 2006; 85 12 1506 1507 (Pubitemid 44863772)
66. Tewari K, Rose GS, Balderston KD, Porto M, Kohler MF. Fertility drugs and malignant germ-cell tumour of ovary in pregnancy. Lancet: 1998; 351 9107 957 958 (Pubitemid 28138475)
67. Tennent BJ, Shultz KL, Sundberg JP, Beamer WG. Ovarian granulosa cell tumorigenesis in SWR-derived F1 hybrid mice: preneoplastic follicular abnormality and malignant disease progression. Am J Obstet Gynecol: 1990; 163 2 625 634 (Pubitemid 20287648)
68. Hahlin M, Crona N, Knutsson F, Janson PO. Human granulosa cell tumor: stimulation of steroidogenesis by gonadotropins in vitro. Gynecol Oncol: 1991; 40 3 201 206
69. Ozdemir I, Ustundag N, Guven A, Duran B, Demirci F. Effect of clomiphene citrate on ovarian, endometrial, and cervical histologies in a rat model. Gynecol Obstet Invest: 2005; 60 4 181 185 (Pubitemid 41551967)
70. Unkila-Kallio L, Leminen A, Tiitinen A, Ylikorkala O. Nationwide data on falling incidence of ovarian granulosa cell tumours concomitant with increasing use of ovulation inducers. Hum Reprod: 1998; 13 1O 2828 2830 (Pubitemid 28482736)
71. Unkila-Kallio L, Tiitinen A, Wahlström T, Lehtovirta P, Leminen A. Reproductive features in women developing ovarian granulosa cell tumour at a fertile age. Hum Reprod: 2000; 15 3 589 593
72. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril: 1996; 65 1 13 18 (Pubitemid 26006641)
73. Parazzini F, Negri E, La Vecchia C., et al. Treatment for fertility and risk of ovarian tumors of borderline malignancy. Gynecol Oncol: 1998; 68 3 226 228 (Pubitemid 28183489)
74. Adewole IF, Babarinsa IA, Thomas JO, Ajayi AB. Ovarian cancer associated with ovulation induction: a case report. Afr J Med Med Sci: 1997; 26 3-4 203 204
75. Bernstein L. Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia: 2002; 7 1 3 15 (Pubitemid 38420778)
76. Parazzini F, La Vecchia C, Negri E, Franceschi S, Tozzi L. Lifelong menstrual pattern and risk of breast cancer. Oncology: 1993; 50 4 222 225 (Pubitemid 23193908)
77. Arbour L, Narod S, Glendon G., et al. In-vitro fertilisation and family history of breast cancer. Lancet: 1994; 344 8922 610 611 (Pubitemid 24267225)
78. Bolton PM. Bilateral breast cancer associated with clomiphene. Lancet: 1977; 2 8049 1176 (Pubitemid 8232012)
79. Brzezinski A, Peretz T, Mor-Yosef S, Schenker JG. Ovarian stimulation and breast cancer: is there a link? Gynecol Oncol: 1994; 52 3 292 295 (Pubitemid 24125542)
80. Jourdain O, Avril A, Mauriac L., et al. Breast cancer and in vitro fertilization. About 32 cases. Eur J Obstet Gynecol Reprod Biol: 1996; 67 1 47 52 (Pubitemid 26178350)
81. Laing RW, Glaser MG, Barrett GS. A case of breast carcinoma in association with in vitro fertilization. J R Soc Med: 1989; 82 8 503
82. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Risk of breast cancer in a cohort of infertile women. Gynecol Oncol: 1996; 60 1 3 7 (Pubitemid 26028448)
83. Terry KL, Willett WC, Rich-Edwards JW, Michels KB. A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Arch Intern Med: 2006; 166 22 2484 2489 (Pubitemid 44913233)
84. Brinton LA, Scoccia B, Moghissi KS., et al. Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod: 2004; 19 9 2005 2013 (Pubitemid 39236465)
85. Gauthier E, Paoletti X, Clavel-Chapelon F.; E3N group. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod: 2004; 19 10 2216 2221 (Pubitemid 39406678)
86. Fisher B, Costantino JP, Wickerham DL., et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst: 1998; 90 18 1371 1388 (Pubitemid 28439961)
87. Kristiansson P, Björ O, Wramsby H. Tumour incidence in Swedish women who gave birth following IVF treatment. Hum Reprod: 2007; 22 2 421 426 (Pubitemid 46152562)
88. Pappo I, Lerner-Geva L, Halevy A., et al. The possible association between IVF and breast cancer incidence. Ann Surg Oncol: 2008; 15 4 1048 1055
89. Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO. Transient increase in the risk of breast cancer after giving birth. N Engl J Med: 1994; 331 1 5 9 (Pubitemid 24195593)
90. Braga C, Negri E, La Vecchia C, Parazzini F, Dal Maso L, Franceschi S. Fertility treatment and risk of breast cancer. Hum Reprod: 1996; 11 2 300 303 (Pubitemid 26089178)
91. Ricci E, Parazzini F, Negri E, Marsico S, La Vecchia C. Fertility drugs and the risk of breast cancer. Hum Reprod: 1999; 14 6 1653 1655 (Pubitemid 29265470)
92. Weiss HA, Troisi R, Rossing MA., et al. Fertility problems and breast cancer risk in young women: a case-control study in the United States. Cancer Causes Control: 1998; 9 3 331 339 (Pubitemid 28319025)
93. Burkman RT, Tang MT, Malone KE., et al. Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril: 2003; 79 4 844 851 (Pubitemid 36385001)
94. Healy DL, Venn A. Infertility medications and the risk of breast cancer. Fertil Steril: 2003; 79 4 852 854; discussion 855 (Pubitemid 36385002)
95. Siegelmann-Danieli N, Tamir A, Zohar H., et al. Breast cancer in women with recent exposure to fertility medications is associated with poor prognostic features. Ann Surg Oncol: 2003; 10 9 1031 1038 (Pubitemid 40486826)
96. Katz D, Paltiel O, Peretz T., et al. Beginning IVF treatments after age 30 increases the risk of breast cancer: results of a case-control study. Breast J: 2008; 14 6 517 522
97. Venn A, Hemminki E, Watson L, Bruinsma F, Healy D. Mortality in a cohort of IVF patients. Hum Reprod: 2001; 16 12 2691 2696 (Pubitemid 34007493)
98. Sprague BL, Trentham-Dietz A, Terry MB, Nichols HB, Bersch AJ, Buist DS. Fertility drug use and mammographic breast density in a mammography screening cohort of premenopausal women. Cancer Epidemiol Biomarkers Prev: 2008; 17 11 3128 3133
99. Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P. Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann N Y Acad Sci: 2001; 943 296 315 (Pubitemid 32928322)
100. Benshushan A, Paltiel O, Brzezinski A., et al. Ovulation induction and risk of endometrial cancer: a pilot study. Eur J Obstet Gynecol Reprod Biol: 2001; 98 1 53 57 (Pubitemid 32758835)
101. Althuis MD, Moghissi KS, Westhoff CL., et al. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol: 2005; 161 7 607 615 (Pubitemid 40411088)
102. Jensen A, Sharif H, Kjaer SK. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study. Am J Epidemiol: 2009; 170 11 1408 1414
103. Varras M, Polyzos D, Akrivis Ch. Effects of tamoxifen on the human female genital tract: review of the literature. Eur J Gynaecol Oncol: 2003; 24 3-4 258 268 (Pubitemid 36644612)
104. Miannay E, Boutemy JJ, Leroy-Billiard M, Gasnault JP, Leroy JL. The possible endometrial risk of ovarian stimulation. Apropos of 3 cases. [in French]. J Gynecol Obstet Biol Reprod (Paris): 1994; 23 1 35 38
105. Felix AS, Weissfeld JL, Stone RA., et al. Factors associated with type I and type II endometrial cancer. Cancer Causes Control: 2010; 21 11 1851 1856